This is what economists might  call a problem of the commons, and the problem of the commons is exactly what we face in the case  of antibiotics as well: that we don't consider — and we, including individuals, patients, hospitals, entire health systems — do not consider the costs  that they impose on others by the way antibiotics are actually used.
Ovo je ono što bi ekonomisti  mogli nazvati problemom zajednice, i problem zajednice je točno ono s čim se suočavamo i u slučaju antibiotika: da ne uzimamo u obzir — i mi, uključujući pojedince, pacijente, bolnice, čitav zdravstveni sustav — ne uzimamo u obzir troškove  koje oni nameću drugima načinom na koji su antibiotici zapravo korišteni.